Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of COVID-19 and risk factors in patients with cancer.
Sengar M, Chinnaswamy G, Ranganathan P, Ashok A, Bhosale S, Biswas S, Chaturvedi P, Dhamne C, Divatia J, D'Sa K, Jain H, Laskar S, Moulik NR, Mummudi N, Nair S, Nayak L, Nayak P, Patkar S, Pawaskar P, Ramaswamy A, Shetty O, Singh A, Sridhar E, Thorat J, Badwe R, Pramesh CS; TMH COVID-19 action group. Sengar M, et al. Among authors: pawaskar p. Nat Cancer. 2022 May;3(5):547-551. doi: 10.1038/s43018-022-00363-4. Epub 2022 Apr 4. Nat Cancer. 2022. PMID: 35379984
Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit.
Khattry N, Laskar S, Sengar M, Rangarajan V, Shet T, Subramanian PG, Epari S, Bagal B, Goda JS, Agarwal A, Jain H, Tembhare P, Patkar N, Khanna N, Punatar S, Gokarn A, Shetty D, Jain H, Bonda A, Gota V, Hasan S, Kode J, Dutt S, Kulkarni S, Shetty N, Sable N, Deodhar J, Jadhav S, Pawaskar P, Mathew L, Menon H, Nair R, Kannan S, Chiplunkar S, Gujral S. Khattry N, et al. Among authors: pawaskar p. Indian J Cancer. 2018 Jan-Mar;55(1):9-15. doi: 10.4103/ijc.IJC_656_17. Indian J Cancer. 2018. PMID: 30147087 Free article.
Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis.
Roy PS, John S, Karankal S, Kannan S, Pawaskar P, Gawande J, Bagal B, Khattry N, Sengar M, Menon H, Gujral S, Nair R. Roy PS, et al. Among authors: pawaskar p. Indian J Med Paediatr Oncol. 2013 Oct;34(4):292-8. doi: 10.4103/0971-5851.125248. Indian J Med Paediatr Oncol. 2013. PMID: 24604960 Free PMC article.
12 results